This year’s Ocular Therapeutics Conference has been divided into four ocular therapeutics evenings (OTEs) due to potential pandemic-related interruptions. The theme for the first was glaucoma.
Associate Professor Ilva Rupenthal, director of the Buchanan Ocular Therapeutics Unit at Auckland University, has been awarded the well-known international Humboldt Fellowship for Experienced Researchers, to help her tackle dry eye disease (DED).
Researchers behind the phase-3 ‘Gobi’ trial of NOV03 (perfluorohexyloctane) eye drops to treat the symptoms of dry eye disease (DED) have reported positive outcomes by day 15 of treatment.
Designed to fuel an optometry or ophthalmology practice’s dry eye offering, French-based ESW Vision’s Tearcheck and Tearstim compact diagnostic and treatment options were on show for the first time in New Zealand on Ophthalmic Instrument Company’s (OIC’s) stand.
Internationally renowned dry eye and ocular surface researcher Professor Jennifer Craig from the University of Auckland has been named as one of the world’s first BCLA ambassadors.
In 2014 I was in my final year overseas preceptorship, shadowing a middle-aged male optometrist. The patient was a lady in her forties. He was on the slit lamp. “Hmm… do you see that?” he asked me. “Madarosis. Could be an autoimmune cause. We need to send her for a blood workup. What tests would you
Launched this year and taking pride of place on Corneal Lens Corporation’s (CLC’s) stand was the company’s latest addition to the Evolve, preservative-free, sterile multi-dose eye drops for dry eye range. Evolve Intensive Gel is a unique combination of Evolve’s Carbomer 980 and its hyaluronate produ
Newly launched the week before the CCLSNZ conference, Systane Ultra preservative-free lubricant eye drops for dry eye are now available in a multi-dose 10ml bottle. Key to the breakthrough is the patented Pureflow technology which features a one-way valve on the tip of the bottle to prevent contamin
February 2020 saw the first cases of Covid-19 appear in New Zealand. Over the following weeks borders were gradually closed and, as we know, New Zealand went into lockdown in the last week of March. CCLSNZ’s one-day conference and the pre-conference myopia management workshop scheduled for the last
Patients suffering from dry eye disease (DED) have a lower quality of life, reporting negative effects on visual function, their ability to carry out daily activities and their work
Though there was no equipment on show (as mandated under alert level two), Optimed’s Craig Norman had brochures galore to help him discuss the new Mediworks dry eye diagnostic system, which had been scheduled for its first public unveiling in New Zealand at the CCLS conference.
GIVEN THE LACK of conferences and seminars due to Covid-19 lockdown restrictions, Peter Stewart from AFT Pharmaceuticals unveiled a host of new products at the CCLSNZ meeting. First up was the timely launch of Crystawash Extend, a gentle, odourless, water-based hand sanitiser that contains no harsh
